South Korea allows phase II human trial for Green Cross's COVID treatment drug

▴ south-korea-allows-direct-phase-2-human-trial-covid-drug
South Korea, desperate for Covid drug skips phase 1 trial

South Korea's Green Cross Corp (006280.KS) has received regulatory approval for phase II human clinical trials of its experimental coronavirus plasma treatment drug, the Ministry of Food and Drug Safety said on Thursday.

The trials will test the safety and efficacy of the drug in 60 severe patients with underlying conditions like pneumonia, Green Cross said.

Green Cross was allowed to skip phase I trials. Its therapy is the country's first to enter phase II for COVID-19 plasma treatment.

South Korea has reported its highest daily rise in coronavirus cases since early March as clusters of cases from churches around the capital Seoul have prompted new restrictions amid concerns of a nationwide wave of infections.

The 297 new infections reported on Wednesday mark the sixth straight day of triple-digit increase in a country that has managed to blunt several previous outbreaks.

The national tally rose to 16,058 infections with 306 deaths, according to data from the Korea Centers for Disease Control and Prevention.

"We're in a desperately dangerous crisis where infections are spreading in the Seoul metropolitan area and threatening to lead to a massive nationwide transmission," Vice Minister of Health Kim Gang-lip told a briefing.

"The government cannot contain the current spread only with tracing and isolation ... please stay home unless you need to go out."

Officials have also enforced stronger physical distancing restrictions for Seoul, Incheon and nearby Gyeonggi province that prohibit gatherings of more than 50 people indoors and 100 people outdoors.


New outbreak
South Korea reported 288 new cases of the virus on Thursday, the majority of which were in Seoul and the surrounding Gyeonggi province. The outbreak has been linked to the Sarang-jeil Church, which has reported hundreds of positive cases among its members, some 400 of whom have yet to be traced by the authorities.

www.reuters.com 

Tags : #SouthKorea #Phase2humantrial #Greencross #CovidDrug #SarangJeilChurch

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024